Vimarsana
Biggest News Aggregation in the World

Page 4 - Rezolute Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rezolute Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rezolute Inc Today - Breaking & Trending Today

Caxton Corp Has $2.61 Million Position in Rezolute, Inc. (NASDAQ:RZLT) - Vimarsana News

Caxton Corp Has $2.61 Million Position in Rezolute, Inc. (NASDAQ:RZLT)

Caxton Corp reduced its holdings in Rezolute, Inc. (NASDAQ:RZLT – Free Report) by 6.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,318,967 shares of the company’s stock after selling 84,190 shares during the quarter. Rezolute accounts for 7.5% of Caxton Corp’s […]

Rezolute (NASDAQ:RZLT) PT Lowered to $7.00 - Vimarsana News

Rezolute (NASDAQ:RZLT) PT Lowered to $7.00

Rezolute (NASDAQ:RZLT – Free Report) had its target price trimmed by JMP Securities from $8.00 to $7.00 in a research note released on Tuesday morning, Benzinga reports. The firm currently has a market outperform rating on the stock. A number of other analysts have also issued reports on RZLT. Cantor Fitzgerald reissued an overweight rating […]

Source: wkrb13.com
Rezolute to Participate in BTIG's 3rd Annual Ophthalmology Day -November 17, 2023 at 08:01 am EST - Vimarsana News

Rezolute to Participate in BTIG's 3rd Annual Ophthalmology Day -November 17, 2023 at 08:01 am EST

REDWOOD CITY, Calif., Nov. 17, 2023 -- Rezolute, Inc. , a clinical-stage biopharmaceutical company committed to developing novel, transformative therapies for serious metabolic and rare diseases,...

Rezolute Receives Priority Medicines (PRIME) Eligibility from European Medicines Agency for ... - Vimarsana News

Rezolute Receives Priority Medicines (PRIME) Eligibility from European Medicines Agency for ...

REDWOOD CITY, Calif., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company committed to developing novel, transformative therapies for serious metabolic and rare diseases, today

Rezolute (NASDAQ:RZLT) Shares Down 2.6% - Vimarsana News

Rezolute (NASDAQ:RZLT) Shares Down 2.6%

Rezolute, Inc. (NASDAQ:RZLT – Get Free Report) shares were down 2.6% during mid-day trading on Friday . The stock traded as low as $0.81 and last traded at $0.87. Approximately 51,270 shares were traded during mid-day trading, an increase of 58% from the average daily volume of 32,480 shares. The stock had previously closed at […]